Old Web
English
Sign In
Acemap
>
authorDetail
>
Jeffrey J. Tryon
Jeffrey J. Tryon
Janssen Pharmaceutica
Medicine
Internal medicine
Prostate cancer
Castration
Oncology
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CULMINATE: A phase II study of cusatuzumab + azacitidine in patients with newly diagnosed AML, ineligible for intensive chemotherapy.
2020
Journal of Clinical Oncology
Geralyn Carol Trudel
Angela Howes
Neelum Jeste
Jeffrey J. Tryon
Liang Xiu
Colleen Kane
Kerri Nottage
Show All
Source
Cite
Save
Citations (1)
A phase Ib/II study of niraparib combination therapies for the treatment of metastatic castration-resistant prostate cancer (NCT03431350).
2019
Journal of Clinical Oncology
Sumit K. Subudhi
Ana Aparicio
Amado J. Zurita
Bernard Doger
William Kevin Kelly
Avivit Peer
Dana E. Rathkopf
Lawrence Ivan Karsh
Jeffrey J. Tryon
Nishi Kothari
Xin Zhao
Eugene Zhu
Deborah Ricci
Namphuong Tran
Johann S. de Bono
Show All
Source
Cite
Save
Citations (2)
1